Arora, Sanjeev

Project ECHO Hepatitis C Ambulatory Care Quality Improvement in New Mexico through Health Information Technology - Final Report

Principal Investigator: 

Demonopolizing medical knowledge.

Principal Investigator: 

Peginterferon alfa-2a does not alter the pharmacokinetics of methadone in patients with chronic hepatitis C undergoing methadone maintenance therapy.

Principal Investigator: 

Ethical issues in the treatment of hepatitis C.

Principal Investigator: 

Treatment of chronic hepatitis C patients with persistently normal alanine aminotransferase levels with the combination of peginterferon alpha-2a (40 kDa) plus ribavirin: impact on health-related quality of life.

Principal Investigator: 

Virological response and safety outcomes in therapy-naive patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 study.

Principal Investigator: 

Widening the door: the evolution of hepatitis C treatment in patients with psychiatric disorders.

Principal Investigator: 

Chronic hepatitis C in pregnancy.

Principal Investigator: 

Project ECHO: Linking university specialists with rural and prison-based clinicians to improve care for people with chronic hepatitis C in New Mexico.

Principal Investigator: